ProQR Therapeutics

$0.00 (0.00%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.

About PRQR

ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Its product pipeline include Sepofarsen, QR-421a, QR-1123, and QR-504a.

CEO
Daniel Anton de Boer
Employees
150
Headquarters
Leiden, Zuid-Holland
Founded
2012

PRQR Key Statistics

Market Cap
498.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
618.23K
High Today
$8.04
Low Today
$7.63
Open Price
$7.71
Volume
358.89K
52 Week High
$9.46
52 Week Low
$3.40

PRQR Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure